Online citations, reference lists, and bibliographies.
← Back to Search

Nanoparticles As Protein And Gene Carriers To Mucosal Surfaces.

M. de la Fuente, N. Csaba, M. Garcia-Fuentes, M. Alonso
Published 2008 · Materials Science, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
One of the most exciting and challenging applications of nanotechnology in medicine is the development of nanocarriers for the intraepithelial delivery of biomacromolecules through mucosal surfaces. These biomacromolecules represent an increasingly important segment of the therapeutic arsenal; however, their potential is still limited by their instability and inability to cross biological barriers. Nanoparticle carriers have emerged as one of the most promising technologies to overcome this limitation, owing mainly to their demonstrated capacity to interact with biological barriers. In this review, we summarize the current advances made on nanoparticles designed for transmucosal delivery. Supported by the examples of a variety of therapeutic macromolecules - peptides and proteins, gene medicines and vaccines - we review the lessons learned from the past and we offer a future perspective for this field.
This paper references
10.1023/A:1018945902276
Uptake of Phosphatidylserine Liposomes by Rat Peyer's Patches Following Intraluminal Administration
H. Tomizawa (2004)
10.1016/J.EJPB.2003.09.006
Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.
A. Vila (2004)
10.3748/WJG.V10.I1.112
Transfection of mEpo gene to intestinal epithelium in vivo mediated by oral delivery of chitosan-DNA nanoparticles.
J. Chen (2004)
10.1016/J.JCONREL.2006.07.021
Development and characterisation of chitosan nanoparticles for siRNA delivery.
Haliza Katas (2006)
10.1080/10611860701637982
M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B
P. Gupta (2007)
10.1038/nrd1721
The rise and rise of drug delivery
Howard Rosen (2005)
10.1016/J.EJPS.2004.12.002
Pegylated nanoparticles based on poly(methyl vinyl ether-co-maleic anhydride): preparation and evaluation of their bioadhesive properties.
K. Yoncheva (2005)
10.1023/A:1014870102295
Controlled DNA Delivery Systems
D. Luo (2004)
10.1016/J.JCONREL.2006.08.021
Effects of alginate inclusion on the vector properties of chitosan-based nanoparticles.
K. L. Douglas (2006)
10.1038/386410A0
Biologically erodable microspheres as potential oral drug delivery systems
E. Mathiowitz (1997)
10.1016/S1773-2247(05)50053-4
Mucosal delivery of diphtheria toxoid using polymer-coated-bioadhesive liposomes as vaccine carriers
C. Martin (2005)
10.1166/JBN.2009.1017
Ionically crosslinked chitosan nanoparticles as gene delivery systems: effect of PEGylation degree on in vitro and in vivo gene transfer.
N. Csaba (2009)
10.1016/S0378-5173(01)00914-0
Effect of the degree of quaternisation of N-trimethyl chitosan chloride on absorption enhancement: in vivo evaluation in rat nasal epithelia.
J. Hamman (2002)
10.1038/7385
Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy
K. Roy (1999)
10.1016/S0928-0987(03)00178-7
The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa.
A. M. de Campos (2003)
10.1016/J.BIOMATERIALS.2006.11.004
The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
X. Liu (2007)
10.1021/BM049577P
PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: new carriers for gene delivery.
N. Csaba (2005)
10.1166/JNN.2007.18113
The Janus faces of nanoparticles.
K. Donaldson (2007)
10.1016/J.JCONREL.2007.06.024
Lectin-conjugated PLGA nanoparticles loaded with thymopentin: ex vivo bioadhesion and in vivo biodistribution.
Yashu Yin (2007)
10.1016/J.ADDR.2003.12.002
Solid lipid nanoparticles for parenteral drug delivery.
S. Wissing (2004)
10.1016/S0169-409X(00)00123-X
Polysaccharide colloidal particles as delivery systems for macromolecules.
K. Janes (2001)
10.1016/S0168-3659(99)00134-0
Branched biodegradable polyesters for parenteral drug delivery systems.
A. Breitenbach (2000)
10.1163/1568562041753098
Design and characterisation of new nanoparticulate polymer blends for drug delivery
N. Csaba (2004)
10.1016/S0928-0987(03)00019-8
Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha.
A. Sánchez (2003)
10.1016/J.JCONREL.2007.04.021
PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination.
M. Garinot (2007)
10.1016/J.JBIOTEC.2007.02.007
Preparation, characterization and transfection efficiency of cationic PEGylated PLA nanoparticles as gene delivery systems.
J. Chen (2007)
10.1016/S0927-7765(99)00157-5
The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration.
Tobío (2000)
10.1002/mabi.200700190
Novel hyaluronan-based nanocarriers for transmucosal delivery of macromolecules.
M. de la Fuente (2008)
10.1016/J.EJPS.2006.10.007
Tuning of shell and core characteristics of chitosan-decorated acrylic nanoparticles.
I. Bravo-Osuna (2007)
10.1586/14760584.4.2.185
Nanoparticles as carriers for nasal vaccine delivery
M. Köping-Höggård (2005)
10.1016/J.IJPHARM.2006.10.031
Encapsulation of mono- and oligo-nucleotides into aqueous-core nanocapsules in presence of various water-soluble polymers.
H. Hillaireau (2007)
10.1073/PNAS.93.4.1585
Cationic facial amphiphiles: a promising class of transfection agents.
S. Walker (1996)
Enzymatic barriers for GI peptide and protein delivery.
Woodley Jf (1994)
10.1016/J.YMTHE.2006.04.010
RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system.
K. Howard (2006)
10.1016/J.EJPS.2007.08.005
Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles.
O. Borges (2007)
10.1021/BM0703923
Oral bioavailability of insulin contained in polysaccharide nanoparticles.
B. Sarmento (2007)
10.1074/JBC.M011553200
Extracellular Glycosaminoglycans Modify Cellular Trafficking of Lipoplexes and Polyplexes*
M. Ruponen (2001)
10.1211/jpp.58.3.0003
Chitosan nanoparticles encapsulated vesicular systems for oral immunization: preparation, in‐vitro and in‐vivo characterization
S. Jain (2006)
10.1016/J.IJPHARM.2006.10.016
Evaluation of bioadhesive potential and intestinal transport of pegylated poly(anhydride) nanoparticles.
K. Yoncheva (2007)
10.1016/S0378-5173(03)00377-6
Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies.
M. Bivas-Benita (2003)
10.1016/J.IJPHARM.2004.12.025
Pharmacological activity of peroral chitosan-insulin nanoparticles in diabetic rats.
Zengshuan Ma (2005)
10.1023/A:1019854327540
Comparative Uptake Studies of Bioadhesive and Non-Bioadhesive Nanoparticles in Human Intestinal Cell Lines and Rats: The Effect of Mucus on Particle Adsorption and Transport
I. Behrens (2004)
10.1016/J.JCONREL.2006.03.017
PLGA:poloxamer and PLGA:poloxamine blend nanostructures as carriers for nasal gene delivery.
N. Csaba (2006)
10.1016/S0378-5173(99)00365-8
Chitosan and its derivatives: potential excipients for peroral peptide delivery systems.
A. Bernkop-Schnürch (2000)
10.1023/A:1011922819926
Stealth PLA-PEG Nanoparticles as Protein Carriers for Nasal Administration
M. Tobío (2004)
10.1023/A:1012128907225
Chitosan and Chitosan/Ethylene Oxide-Propylene Oxide Block Copolymer Nanoparticles as Novel Carriers for Proteins and Vaccines
P. Calvo (2004)
10.2337/diab.37.2.246
New Approach for Oral Administration of Insulin With Polyalkylcyanoacrylate Nanocapsules as Drug Carrier
C. Damgé (1988)
10.1016/J.YMETH.2005.11.003
Diphtheria toxoid loaded poly-(ε-caprolactone) nanoparticles as mucosal vaccine delivery systems
J. Singh (2006)
Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.
R. E. Eliaz (2001)
10.1080/03639040601050163
Development and In Vitro Evaluation of Surface Modified Poly(lactide-co-glycolide) Nanoparticles with Chitosan-4-Thiobutylamidine
V. Grabovac (2007)
10.1021/LA049505J
Application of NMR spectroscopy to the characterization of PEG-stabilized lipid nanoparticles.
M. Garcia-Fuentes (2004)
10.1002/PAT.280
PLA‐PEG nanospheres: new carriers for transmucosal delivery of proteins and plasmid DNA
A. Vila (2002)
10.1016/S0168-3659(00)00361-8
Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency.
H. Mao (2001)
Influence of coating agents on the degradation of poly(D,L-lactic acid) nanoparticles in model digestive fluids (USP XXII)
F. J. Landry (1996)
10.1042/BST0350527
Health effects of nanomaterials.
T. Tetley (2007)
10.1088/0957-4484/19/18/185101
Novel drug nanocarriers combining hydrophilic cyclodextrins and chitosan.
A. Trapani (2008)
10.1016/J.JCONREL.2006.03.013
Hyaluronic acid and its derivative as a multi-functional gene expression enhancer: protection from non-specific interactions, adhesion to targeted cells, and transcriptional activation.
T. Ito (2006)
10.1016/J.IJPHARM.2005.10.016
Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery.
A. Krauland (2006)
10.1016/j.ijpharm.2007.11.027
Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.
Kapil Khatri (2008)
10.1023/A:1018908705446
Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles
R. Fernández-Urrusuno (2004)
10.1016/S0169-409X(00)00120-4
Mucoadhesive nanoparticulate systems for peptide drug delivery.
H. Takeuchi (2001)
10.1016/J.IJPHARM.2006.11.027
Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers.
Fu Chen (2007)
10.1023/A:1011063232257
Tetanus Toxoid Loaded Nanoparticles from Sulfobutylated Poly(Vinyl Alcohol)-Graft-Poly(Lactide-co-Glycolide): Evaluation of Antibody Response After Oral and Nasal Application in Mice
T. Jung (2004)
10.1167/iovs.07-1077
Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy.
M. de la Fuente (2008)
10.1023/A:1016085108889
Gastrointestinal Uptake of Biodegradable Microparticles: Effect of Particle Size
M. P. Desai (2004)
10.1007/s11095-006-9563-7
Gene Expression Profiles in Mouse Lung Tissue after Administration of Two Cationic Polymers Used for Nonviral Gene Delivery
K. Regnström (2006)
10.1016/J.IJPHARM.2007.03.005
Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system.
A. Krauland (2007)
10.1166/JNN.2006.435
Development of phosphorylated glucomannan-coated chitosan nanoparticles as nanocarriers for protein delivery.
M. Cuña (2006)
10.1016/j.addr.2012.09.004
Biodegradation and biocompatibility of PLA and PLGA microspheres.
Shive (1997)
10.1016/J.EJPB.2007.08.009
Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles.
X. Zhang (2008)
10.1038/nnano.2007.217
Targeted delivery of magnetic aerosol droplets to the lung
P. Dames (2007)
10.1016/J.EJPB.2005.12.006
A new drug nanocarrier consisting of chitosan and hydoxypropylcyclodextrin.
F. Maestrelli (2006)
10.1016/J.VACCINE.2003.11.011
Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1.
S. Gogev (2004)
10.1016/J.JCONREL.2005.12.013
Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel.
J. Kim (2006)
10.1002/jgm.1125
Low molecular weight hyaluronan shielding of DNA/PEI polyplexes facilitates CD44 receptor mediated uptake in human corneal epithelial cells
M. Hornof (2008)
10.1016/S0168-3659(01)00397-2
Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA.
C. Pérez (2001)
10.1016/J.JCONREL.2005.12.015
Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree.
C. Prego (2006)
10.1016/J.IJPHARM.2007.03.039
UEA I-bearing nanoparticles for brain delivery following intranasal administration.
X. Gao (2007)
10.1016/J.VACCINE.2006.06.086
N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model.
M. Amidi (2007)
10.1111/j.2042-7158.1990.tb07033.x
Nanoparticle Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency
P. Jani (1990)
10.1023/B:PHAM.0000022414.17183.58
Novel Chitosan Particles and Chitosan-Coated Emulsions Inducing Immune Response via Intranasal Vaccine Delivery
Takahiro Nagamoto (2004)
10.1016/J.JCONREL.2004.07.030
Transmucosal macromolecular drug delivery.
C. Prego (2005)
10.1007/S003960050050
Development of positively charged colloidal drug carriers: Chitosan-coated polyester nanocapsules and submicron-emulsions
P. Calvo (1997)
10.1016/J.NANO.2007.03.006
Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides.
N. Nafee (2007)
10.1021/MA060230J
Formation of New Glucomannan−Chitosan Nanoparticles and Study of Their Ability To Associate and Deliver Proteins
M. Alonso-Sande (2006)
10.1016/J.IJPHARM.2004.12.030
New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin.
M. Garcia-Fuentes (2005)
10.1038/gt.2008.16
Bioadhesive hyaluronan–chitosan nanoparticles can transport genes across the ocular mucosa and transfect ocular tissue
M. Fuente (2008)
10.1023/A:1007582911958
Visual Evidence of Acidic Environment Within Degrading Poly(lactic-co-glycolic acid) (PLGA) Microspheres
K. Fu (2004)
10.1016/S0927-7765(02)00053-X
Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules
M. Garcia-Fuentes (2003)
10.1016/S0378-5173(02)00486-6
Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo.
Yan Pan (2002)
10.1016/J.EJPS.2005.04.009
Microencapsulated chitosan nanoparticles for lung protein delivery.
A. Grenha (2005)
10.1016/S0378-5173(97)00083-5
Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers
P. Calvo (1997)
10.1038/nbt1006-1211
The emerging nanomedicine landscape
Volker Wagner (2006)
10.1016/S0169-409X(01)00184-3
Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas.
A. Florence (2001)
10.1016/S0168-3659(01)00486-2
Design of biodegradable particles for protein delivery.
A. Vila (2002)
10.1002/JPS.20728
A practical approach to the use of nanoparticles for vaccine delivery.
J. Wendorf (2006)
10.2147/NANO.2006.1.2.173
Efficient gene transfection using chitosan–alginate core-shell nanoparticles
Jin-Oh You (2006)
10.1016/J.BIOMATERIALS.2007.01.005
Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles.
I. Bravo-Osuna (2007)
10.2174/156720106778559029
Particulate systems as adjuvants and carriers for peptide and protein antigens.
M. Liang (2006)
10.1166/JNN.2006.418
Bioadhesive properties of poly(alkylcyanoacrylate) nanoparticles coated with polysaccharide.
I. Bertholon (2006)
10.1016/S0939-6411(00)00087-4
Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.
R. Mueller (2000)
10.1016/J.BIOMATERIALS.2006.11.028
Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP).
Y. Diebold (2007)
10.1023/A:1016015803611
Polyester Nanocapsules as New Topical Ocular Delivery Systems for Cyclosporin A
P. Calvo (2004)
10.1016/S0939-6411(00)00084-9
Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?
T. Jung (2000)
10.1016/J.IJPHARM.2006.02.044
Thiomers: preparation and in vitro evaluation of a mucoadhesive nanoparticulate drug delivery system.
A. Bernkop-Schnürch (2006)
10.1016/J.VACCINE.2006.01.011
Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.
K. S. Jaganathan (2006)
10.1111/j.2042-7158.1991.tb05437.x
The Effect of Site of Administration in the Gastrointestinal Tract on the Absorption of Insulin from Nanocapsules in Diabetic Rats
C. Michel (1991)
10.1016/0378-5173(92)90202-D
Nanosphere and microsphere uptake via Peyer's patches: observation of the rate of uptake in the rat after a single oral dose
P. U. Jani (1992)
10.1016/J.IJPHARM.2006.02.026
A novel chitosan oligosaccharide-stearic acid micelles for gene delivery: properties and in vitro transfection studies.
F. Hu (2006)
Development of a freeze-dried formulation of insulin-loaded chitosan nanoparticles intended for nasal administration
R. Fernández-Urrusuno (1999)
10.1038/71889
Synthetic DNA delivery systems
D. Luo (2000)
10.1166/JNN.2007.041
Chitosan-TPP nanoparticle as a release system of antisense oligonucleotide in the oral environment.
T. H. Dũng (2007)
10.1517/17425247.3.4.463
The performance of nanocarriers for transmucosal drug delivery
N. Csaba (2006)
10.1016/J.JCONREL.2005.09.014
AIDS vaccine: Intranasal immunization using inactivated HIV-1-capturing core-corona type polymeric nanospheres.
T. Akagi (2005)
10.1016/J.JCONREL.2007.05.026
Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration.
X. Gao (2007)
10.1016/S0945-053X(01)00186-X
CD44-mediated uptake and degradation of hyaluronan.
W. Knudson (2002)
10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4
Novel hydrophilic chitosan‐polyethylene oxide nanoparticles as protein carriers
P. Calvo (1997)
10.1023/A:1016009313548
Enteral Absorption of Insulin in Rats from Mucoadhesive Chitosan-Coated Liposomes
H. Takeuchi (2004)
10.1081/PDT-100100522
Mucoadhesive DL-Lactide/Glycolide Copolymer Nanospheres Coated with Chitosan to Improve Oral Delivery of Elcatonin
Y. Kawashima (2000)
10.1016/S0939-6411(97)00056-8
Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres
M. D. Blanco (1997)
10.1016/J.JCONREL.2006.09.015
Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin.
Yashu Yin (2006)
10.1002/JMV.10279
Mucosal immunization with inactivated HIV‐1‐capturing nanospheres induces a significant HIV‐1‐specific vaginal antibody response in mice
Takami Akagi (2003)
10.1016/J.EJPS.2005.02.008
A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery.
M. Garcia-Fuentes (2005)
10.1016/J.EJPB.2004.03.023
Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
S. M. van der Merwe (2004)
10.1021/JS970124I
Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin.
C. Damgé (1997)



This paper is referenced by
10.4155/tde.13.99
Pullulan-based nanoparticles: future therapeutic applications in transmucosal protein delivery.
A. Grenha (2013)
10.1016/j.jconrel.2011.02.002
Vaginal delivery of siRNA using a novel PEGylated lipoplex-entrapped alginate scaffold system.
S. Wu (2011)
10.1016/j.addr.2009.11.026
Chitosan-based nanostructures: a delivery platform for ocular therapeutics.
M. de la Fuente (2010)
10.1016/j.ejps.2013.04.018
Pullulan-based nanoparticles as carriers for transmucosal protein delivery.
M. Dionísio (2013)
Nanocápsulas policatiónicas: nuevos sistemas para la liberación intracelular de fármacos antitumorales
María Victoria Lozano López (2011)
10.1016/B978-0-444-53349-4.00257-0
10.06 – Nanochitins and Nanochitosans, Paving the Way to Eco-Friendly and Energy-Saving Exploitation of Marine Resources
R.A.A. Muzzarelli (2012)
10.1002/ADMA.201201800
Mucus penetrating nanoparticles: biophysical tool and method of drug and gene delivery.
Laura M Ensign (2012)
10.1007/978-1-4939-7312-5_21
Polyester-Based Nanoparticles for Delivery of Therapeutic Proteins.
P. Fonte (2018)
10.1002/9781119962977.CH11
Chitosan‐Based Systems for Mucosal Delivery of Biopharmaceuticals
S. Al-Qadi (2012)
10.1016/j.addr.2011.02.008
New developments and opportunities in oral mucosal drug delivery for local and systemic disease.
V. Hearnden (2012)
10.3109/1061186X.2011.654121
Chitosan nanoparticles: a survey of preparation methods
A. Grenha (2012)
10.3390/ma8095268
Biocompatibility and Stability of Polysaccharide Polyelectrolyte Complexes Aimed at Respiratory Delivery
Susana Rodrigues (2015)
10.1080/17425247.2020.1776698
Polyaminoacid-based nanocarriers: a review of the latest candidates for oral drug delivery
Sandra Robla (2020)
10.1007/978-1-84882-448-5_7
Clinical Research in the Postgenomic Era
S. Meystre (2012)
10.1016/J.AJPS.2013.09.002
Prodrugs incorporated into nanotechnology-based drug delivery systems for possible improvement in bioavailability of ocular drugs delivery
Tiantian Ye (2013)
10.1159/000441898
Topical Administration Is a Promising Inoculating Route versus Intramuscular Inoculation for the Nanoparticle-Carried DNA Vaccine to Prevent Corneal Infections
K. Hu (2015)
10.1016/j.actbio.2015.03.029
Surface charge tunability as a powerful strategy to control electrostatic interaction for high efficiency silencing, using tailored oligopeptide-modified poly(beta-amino ester)s (PBAEs).
Pere Dosta (2015)
10.1016/J.NHTM.2014.11.058
Revolutionary impact of nanovaccines on immunotherapy
M. Shahbazi (2014)
10.1007/s11356-017-8801-3
Interaction of TiO2 nanoparticles with proteins from aquatic organisms: the case of gill mucus from blue mussel
Adeline Bourgeault (2017)
10.1016/j.ijpharm.2014.01.037
Freeze-drying of ovalbumin loaded mesoporous silica nanoparticle vaccine formulation increases antigen stability under ambient conditions.
K. T. Mody (2014)
A REVIEW O CHITOSA BASED AOPARTICLE AS A EW OCULAR DRUG DELIVERY
M. Shivashankar (2011)
10.3390/POLYM3041972
Water Soluble Polymers for Pharmaceutical Applications
Veeran Gowda Kadajji (2011)
10.1016/j.jconrel.2012.03.017
Chitosan-based drug nanocarriers: where do we stand?
M. Garcia-Fuentes (2012)
10.4155/TDE.12.40
Polymer-based oral peptide nanomedicines.
E. P. Herrero (2012)
10.1002/jps.23512
Nanovesicles system for rapid-onset sublingual delivery containing sodium tanshinone IIA sulfonate: in vitro and in vivo evaluation.
H. Zhu (2013)
10.1016/j.biomaterials.2012.03.041
Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype.
Stacey L. Demento (2012)
Transmukozna primjena lijekova kroz sluznicu usne šupljine
Marinka Mravak-Stipetić (2012)
Improvement of antimicrobial activity of quinazolinone derivatives by loading into chitosan/TPP nanoparticles.
Nehal A. Salahuddin (2016)
DETERMINING THE ROLE OF MUC1 AND BETA-CATENIN ON THE EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING AND LOCALIZATION IN BREAST CANCER
B. Bitler (2010)
10.1016/j.vaccine.2010.12.031
An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice.
K. Hu (2011)
10.1016/j.ijpharm.2018.11.027
Biocompatibility studies of intravenously administered ionic‐crosslinked chitosan‐BSA nanoparticles as vehicles for antitumour drugs
N. Montero (2019)
10.4274/tjps.galenos.2019.48751
Nanocarriers Used Most in Drug Delivery and Drug Release: Nanohydrogel, Chitosan, Graphene, and Solid Lipid
S. Özkan (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar